GABAergic systems modulate nicotinic receptor-mediated seizures in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 3, 2003, Pages 1159-1166

  Dobelis, Peter ^a   Hutton, Scott ^b   Lu, Ying ^b   Collins, Allan C ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ACETYLCHOLINE; AMINO ACID RECEPTOR; ANABASINE; BICUCULLINE; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; EPIBOXIDINE; KAINIC ACID; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; PICROTOXIN; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; CONVULSANTS; GAMMA-AMINOBUTYRIC ACID; MICE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SEIZURES; TRITIUM;

EID: 0042433181     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.053066     Document Type: Article

References (42)

1. Alkondon M and Albuquerque EX (2001) Nicotinic acetylcholine receptor α7 and α4β2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 86:3043-3055.
2. Alkondon M, Pereira EF, and Albuquerque EX (1998) α-Bungarotoxinand methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810:257-263.
3. Alkondon M, Pereira EF, Eisenberg HM, and Albuquerque EX (2000) Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 20:66-75.
4. Aramakis VB and Metherate R (1998) Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J Neurosci 18:8485-8495.
5. Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, et al. (1994) (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J Pharmacol Exp Ther 270:310-318.
6. Avoli M, Barbarosie M, Lucke A, Nagao T, Lopantsev V, and Köhling R (1996) Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci 16:3912-3924.
7. Broide RS, Salas R, Ji D, Paylor R, Patrick JW, Dani JA, and De Biasi M (2002) Increased sensitivity to nicotine-induced seizures in mice expressing the L250T α7 nicotinic acetylcholine receptor mutation. Mol Pharmacol 61:695-705.
8. Buhler AV and Dunwiddie TV (2002) Regulation of the activity of hippocampal stratum oriens interneurons by α7 nicotinic acetylcholine receptors. Neuroscience 106:55-67.
9. Buisson B and Bertrand D (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23:130-136.
10. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
11. Chiodini FC, Tassonyi E, Hulo S, Bertrand D, and Muller D (1999) Modulation of synaptic transmission by nicotine and nicotinic antagonists in hippocampus. Brain Res Bull 48:623-628.
12. Cohen SL, Morley BJ, and Snead OC (1981) An EEG analysis of convulsive activity produced by cholinergic agents. Prog Neuropsychopharmacol 5:383-388.
13. Damaj MI, Glassco W, Dukat M, and Martin BR (1999) Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 291:1284-1291.
14. de Fiebre CM, Meyer EM, Henry JC, Muraskin SI, Kem WR, and Papke RL (1995) Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic α7/125I-alpha-bungarotoxin receptor subtypes. Mol Pharmacol 47:164-171.
15. Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A, Schwarz J, Collins AC, Lebaraca C, and Lester HA (2003) Increased sensitivity to agonist-induced seizures, straub tail and hippocampal theta rhythm in knockin-mice carrying hypersensitive α4 nicotinic receptors. J Neurosci 23:2582-2590.
16. Franceschini D, Paylor R, Broide R, Salas R, Bassetto L, Gotti C, and De Biasi M (2002) Absence of α7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Res Mol Brain Res 98:29-40.
17. Frazier CJ, Buhler AV, Weiner JL, and Dunwiddie TV (1998b) Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18:8228-8235.
18. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, and Dunwiddie TV (1998a) Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 18:1187-1195.
19. Freund RK, Jungschaffer DA, Collins AC, and Wehner JM (1988) Evidence for modulation of GABAergic neurotransmission by nicotine. Brain Res 453:215-220.
20. Fujii S, Ji Z, and Sumikawa K (2000a) Inactivation of α7 ACh receptors and activation of non-α7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci Lett 286:134-138.
21. Fujii S, Jia Y, Yang A, and Sumikawa K (2000b) Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Res 863:259-265.
22. Houlihan LM, Slater Y, Guerra DL, Peng J-H, Kou Y-P, Lukas RJ, Cassels BK, and Bermudez I. (2001) Activity of cytisine and its brominated isosteres on recombinant human α7, α4β2 and α4β4 nicotinic acetylcholine receptors. J Neurochem 78:1029-1043.
23. Itier V and Bertrand D (2001) Neuronal nicotinic receptors: from protein structure to function. FEBS Lett 504:118-125.
24. Ji D and Dani JA (2000) Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 83:2682-2690.
25. Ji D, Lape R, and Dani JA (2001) Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31:131-141.
26. Köhling R, Vreugdenhil M, Bracci E, and Jefferys JG (2000) Ictal epileptiform activity is facilitated by hippocampal GABAA receptor-mediated oscillations. J Neurosci 20:6820-6829.
27. Kosobud AE and Crabbe JC (1990) Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs. Brain Res 526:8-16.
28. Kosobud AE, Cross SJ, and Crabbe JC (1992) Neural sensitivity to pentylenetetrazol convulsions in inbred and selectively bred mice. Brain Res 592:122-128.
29. Litchfield ST and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
30. Loscher W, Potschka H, Wlaz P, Danyz W, and Parsons CG (2003) Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats. Eur J Pharmacol 466:99-111.
31. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux JP, and Collins AC (1998) Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther 287:648-657.
32. 3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther 291:1127-1134.
33. McGehee DS, Heath MJ, Gelber S, Devay P, and Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science (Wash DC) 269:1692-1696.
34. Miner LL and Collins AC (1989) Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 33:469-475.
35. Miner LL, Marks MJ, and Collins AC (1984) Classical genetic analysis of nicotine-induced seizures and nicotinic receptors. J Pharmacol Exp Ther 231:545-554.
36. Pedigo NW, Dewey WL, and Harris LS (1975) Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther 193:845-852.
37. Picciotto MR, Brunzell DH, and Caldarone BJ (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13:1097-1106.
38. Raggenbass M and Bertrand D (2002) Nicotinic receptors in circuit excitability and epilepsy. J Neurobiol 53:580-589.
39. Stevens K, Meltzer J, and Rose GM (1995) Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats, Psychopharmacology 119:163-170.
40. Stitzel JA, Blanchette JM, and Collins AC (1998) Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the α5 and α7 nicotinic receptor subunit genes. J Pharmacol Exp Ther 284:1104-1111.
41. Stitzel JA, Jimenez M, Marks MJ, Tritto T, and Collins AC (2000) Potential role of the α4 and α6 nicotinic receptor subunits in regulating nicotine-induced seizures. J Pharmacol Exp Ther 293:67-74.
42. Wong JY, Ross SA, McColl C, Massalas JS, Powney E, Finkelstein DI, Clark M, Horne MK, Berkovic SF, and Drago J (2002) Proconvulsant-induced seizures in alpha(4) nicotinic acetylcholine receptor subunit knockout mice. Neuropharmacology 43:55-64.